Hilleman Laboratories
Tracked across 2 events · 551 articles · First seen Mar 09, 2018 · Last active Aug 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Accidents
The Democratic Republic of the Congo is experiencing its largest and fastest-growing Ebola outbreak on record, caused by the rare Bundibugyo virus for which there are no approved vaccines or treatments. The outbreak, declared on…
Impact: Developing a promising rVSV-based Bundibugyo vaccine, with WHO calling it the 'most promising' candidate. Its progress could provide a key tool against the outbreak.
Mar 09, 2018 · 543 articles
Accidents
The Democratic Republic of the Congo received its first shipment of more than 16,000 doses of the Ervebo Ebola vaccine on August 22, 2026, as the country battles its deadliest Ebola outbreak on record. The…
Impact: Hilleman Laboratories is developing the rVSV Bundibugyo vaccine, described by WHO as the most promising candidate. Its success could be significant for the company and outbreak control.
Aug 22, 2026 · 8 articles
79
Hilleman Laboratories announced developmentDRC Ebola outbreak spreads...
79
Hilleman Laboratories developed promising vaccineDRC Ebola outbreak spreads...
60
Hilleman Laboratories announced developmentEbola vaccine doses arrive in DRC
60
Merck Group served as technical adviser Hilleman LaboratoriesDRC Ebola outbreak spreads...
Coalition for Epidemic Preparedness Innovations
grantee
↔
Hilleman Laboratories
Hilleman Laboratories is a key grantee and development partner of Coalition for
Coalition for Epidemic Preparedness Innovations
funder
↔
Hilleman Laboratories
Coalition for Epidemic Preparedness Innovations (CEPI) provides significant gran
ERGEN INTELLIGENCE
Track Hilleman Laboratories live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard